Additionally, Keap1-independent activation of Nrf2 has been shown to be associated with resistance to EGFR-TKI despite expression of the wild-type EGFR gene in NSCLC cells [18]. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.